Diabetic peripheral neuropathy, or DPN, is one of the most common chronic complications of diabetes. Persistently elevated blood glucose can damage peripheral nerves through several overlapping biological processes, including oxidative stress, impaired microvascular blood flow and abnormal metabolism within nerve cells. The longest nerves are generally affected first, which is why symptoms often begin in the toes and feet before moving upward in a “stocking” pattern. Patients may experience burning, electric-shock sensations, pins and needles, numbness, exaggerated sensitivity to touch or an inability to feel injuries. Because sensory feedback is disrupted, a minor wound can go unnoticed and develop into a serious ulcer. Pain and altered sensation can also interfere with walking, sleep, employment, social roles and emotional well-being.

Existing treatments for painful DPN typically combine improved diabetes management with medicines that target nerve pain, such as certain anticonvulsants, antidepressants or topical therapies. These approaches can reduce symptoms for some patients, but their effects are often incomplete, and adverse reactions may include dizziness, drowsiness, gastrointestinal problems or other complications. Nerve damage itself may not be reversed by symptom control. That has driven interest in non-drug approaches, including psychological therapies, exercise and mindfulness-based interventions, or MBIs. Mindfulness is not simply “thinking positively” or attempting to empty the mind. It is a trainable form of attention in which a person deliberately notices present-moment sensations, thoughts and emotions with less automatic judgment or avoidance. Programs may use breathing exercises, body scans, gentle movement and guided observation of pain.

The biological rationale for using mindfulness in chronic pain is different from the rationale for treating the underlying neuropathy. Mindfulness cannot restore damaged axons or directly normalize blood glucose. It may, however, influence how the nervous system processes and responds to unpleasant sensations. Pain is shaped not only by incoming signals from injured tissue but also by attention, threat appraisal, emotional distress, sleep and central nervous-system modulation. When a painful sensation is interpreted as an immediate danger, anxiety and muscle tension can amplify suffering, creating a feedback loop that makes symptoms feel more intrusive. Mindfulness training aims to help patients distinguish the raw sensory experience from the additional fear, catastrophic interpretation and behavioral restriction that can surround it. Earlier research in diabetes and chronic pain has reported potential benefits for distress and quality of life, but evidence specific to DPN remains limited.

To investigate why MBIs are rarely implemented among people with DPN, Qing Fan and colleagues at the First Affiliated Hospital of Dalian Medical University in China conducted a descriptive qualitative study with a phenomenological orientation. The researchers purposively recruited 14 patients who met the study’s inclusion criteria and conducted semi-structured, in-depth interviews. Rather than measuring pain scores before and after a treatment, phenomenological research examines how people experience and make sense of a condition or intervention. The interviews were analyzed using Colaizzi’s seven-step method, which involves extracting significant statements, formulating meanings, organizing them into themes and returning to participants’ accounts to ensure that the interpretation reflects their experiences. Member checking and peer debriefing were used to strengthen credibility, while the protocol received ethics approval and all participants provided written consent.

The analysis produced three core themes and seven subthemes. The first was psychological anxiety arising from physiological symptoms. Participants described the combined burden of chronic disease, persistent discomfort and uncertainty about whether their current treatment was working. DPN does not occur in isolation: patients must often monitor glucose, take medicines, attend appointments, adjust their diet and respond to other diabetes complications while coping with sensations that can be invisible to family members and clinicians. Changes in physical ability may alter employment, caregiving and household responsibilities, creating therapeutic stress as social roles shift. Dissatisfaction with symptom relief can further erode motivation, particularly when a new intervention appears to demand effort without offering a guaranteed result.

The second theme concerned how patients understood and accepted mindfulness. Some participants appeared to associate it with religious practice, passive relaxation or a technique that should produce immediate symptom elimination. Such assumptions matter because mindfulness-based care is usually cumulative: its proposed benefits depend on repeated practice, improved awareness and changes in the relationship to symptoms rather than an instant anesthetic effect. A person who expects the first session to remove burning pain may quickly conclude that the intervention has failed. Others may fear that mindfulness implies their pain is psychological or that clinicians are dismissing the biological basis of nerve injury. The researchers therefore identify patient education as a central implementation requirement. Explaining the difference between changing pain perception and repairing nerve damage could prevent both unrealistic expectations and the stigma associated with mental-health care.

The third theme revealed differentiated expectations about how mindfulness should be delivered and what it should accomplish. Patients did not necessarily want the same program, schedule or outcome. Some may prioritize better sleep and emotional stability, while others are more concerned with walking, daily function or coping during severe pain. Preferences may also vary between face-to-face instruction, brief home exercises, telephone support and digital delivery through an application. A long, standardized course may be unrealistic for someone working irregular hours, managing mobility problems or traveling a considerable distance for hospital care. Digital tools could provide short guided sessions, reminders and progress tracking, but the study also highlights the digital divide: access to smartphones, reliable internet, technical confidence and private space cannot be assumed. Technology may widen disparities unless programs include low-bandwidth, offline or non-digital alternatives.

The researchers describe a core contradiction between patients’ disease-management needs and their actual life circumstances. People with DPN may be highly motivated to reduce suffering but have limited time, money, transportation, family support or energy. Pain itself can make sitting still or focusing on the body difficult, especially when numbness and hypersensitivity alternate. Anxiety and frustration can undermine adherence, while social and economic pressures compete with practice. These findings shift attention away from blaming patients for “noncompliance” and toward contextualized care. A viable intervention might begin with several minutes of practice rather than an hour, offer adaptations for foot pain and mobility limitations, provide instruction in ordinary clinical settings and involve family members when appropriate. It could also connect mindfulness with established foot-care education, physical activity and psychological support rather than presenting it as a stand-alone solution.

The study’s conclusions point toward a multidisciplinary implementation pathway involving diabetologists, neurologists, nurses, psychologists, physiotherapists and digital-health specialists. A DPN-specific program would need to be tested—not merely assumed effective—in properly designed clinical trials that measure pain intensity, sleep, mood, physical function, diabetes distress, quality of life and possibly glycemic outcomes. Researchers would also need to monitor adverse experiences and determine which patients benefit, how much practice is required and whether gains persist. Because this initial study involved only 14 patients from a single tertiary hospital, its themes cannot be treated as representative of every person with DPN or as proof that mindfulness improves neuropathy. It was not preregistered, and no dataset was generated or analyzed for public release. Still, the findings offer a potentially important lesson for viral wellness culture and clinical medicine alike: an intervention’s promise is only as strong as its fit with patients’ lives. For people whose nerves are damaged and whose daily routines are already overloaded, making mindfulness accessible may be as important as making it scientifically credible.

Subject of Research: Barriers and facilitators affecting the adoption of mindfulness-based interventions among patients with diabetic peripheral neuropathy

Article Title: Barriers and Facilitators to Mindfulness-Based Interventions in Diabetic Peripheral Neuropathy: A Qualitative Inquiry to Inform Intervention Design

Article References: Fan, Q., Zhang, W., Liu, Y. et al. “Barriers and Facilitators to Mindfulness-Based Interventions in Diabetic Peripheral Neuropathy: A Qualitative Inquiry to Inform Intervention Design.” Mindfulness (2026). Original research article

Image Credits: AI Generated

DOI: 10.1007/s12671-026-02969-6

Keywords: diabetic peripheral neuropathy, mindfulness-based intervention, chronic pain, diabetes distress, qualitative research, implementation science, patient-centered care, digital health

As the study unfolded within the context of the humanitarian crisis in 2025, researchers Ahmed et al. swiftly addressed the multifaceted nature of DKA. It is crucial to note that DKA is not merely a consequence of poorly managed diabetes, but also reflects a broader spectrum of neglect within healthcare frameworks that fail to support vulnerable populations. The research highlights that socioeconomic factors, including food insecurity and lack of access to insulin and other medical resources, exacerbate the risk of DKA among individuals living with diabetes, illustrating the unrelenting cycle of poverty and health challenges in crisis zones.

The findings of this cross-sectional study were revealing; it was alarming yet not surprising to find that DKA is not only a complication of diabetes, but also a preventable condition when proper education, resources, and healthcare access are available. Patients were often presenting at hospitals in severe metabolic distress, suggesting that their condition had reached critical levels before intervention could take place. Shifting the focus towards preventive measures and education could potentially reduce the occurrence of DKA. This aspect of health education cannot be overstated, as timely treatment and proper management of diabetes are necessary to avoid the complications inherent to this condition.

Moreover, the study showcased a worrying trend among the demographic most affected, which included younger adults and children, further implicating the need for tailored health services that specifically cater to younger populations suffering from diabetes. Alarmingly, many of these young patients had been living with diabetes without a proper support system in place, leading to profound misunderstandings of their condition and inadequate monitoring of blood glucose levels. In light of such sobering trends, the role of healthcare professionals as educators comes to the forefront, emphasizing their crucial part in bridging knowledge gaps in communities.

Access to necessary medication, like insulin, has also been a critical topic within the study. Interviews revealed that many diabetic patients in northern Sudan simply could not obtain insulin regularly due to scarcity and high costs, which often left them with no choice but to forgo their treatment. This situation not only increases their risk for DKA but reflects a systemic failure to prioritize diabetic care. It begs the question: how can a nation begin to address such fundamental issues that contribute to preventable health crises?

To complicate matters, the ongoing humanitarian crisis, which has led to severe resource shortages, greatly impacts the supply chain of essential medicines and healthcare services. Healthcare providers are often left to manage an influx of patients presenting with acute complications, such as DKA, with inadequate resources, making emergency care a monumental challenge. This crisis illustrates a need for immediate intervention strategies that elevate diabetic care to a priority level amidst broader health concerns.

Following the researchers’ assessments, it is evident that investment in sustainable healthcare solutions is urgent. Educational programs aimed at community awareness around diabetes and its complications must be established, not only to help prevent DKA but also to foster a supportive environment for those impacted by diabetes. Furthermore, the establishment of dedicated support networks could serve to empower patients, offering them guidance and resources so they are better equipped to manage their condition.

Although DKA may manifest swiftly and severely, it does not have to be the fatal outcome many individuals face. With advances in clinical management, there is a pivotal opportunity for health systems to implement protocols that prioritize early detection and intervention. Training healthcare providers in both urban and rural settings to recognize the early signs of DKA could be transformative. The question remains: how can we ensure these protective measures reach the most affected populations, especially within a framework challenged by socioeconomic barriers?

The study ultimately contributes invaluable insights to the global dialogue surrounding diabetes care, particularly in fragile contexts. As diabetes prevalence escalates worldwide, it is critical that healthcare initiatives are designed to comprehend and tackle the intricate, interwoven challenges posed by socio-economic hardships. Fostering an inclusive approach where health policies are not merely reactive, but proactive, should be the goals of healthcare authorities moving ahead, providing necessary health coverage for diabetic patients and ensuring that no one is left behind in managing their chronic conditions.

The nuanced challenges illustrated in the research compel us to think beyond conventional healthcare models. As we strive for equitable health outcomes, adapting our strategies to fit the unique needs of populations affected by crises will be essential in preventing the spiraling complexities of DKA and other complications of diabetes.

In conclusion, the alarming rise of DKA presents a compelling call to action. Addressing this public health concern requires comprehensive strategies that encompass education, resource allocation, and a commitment to sustaining healthcare in the most challenging environments. Only with such dedication can we hope to alleviate the burden of diabetic complications and promote healthy, thriving communities in the face of adversity.

Subject of Research: Diabetic ketoacidosis prevalence and patterns among diabetic patients in northern Sudan during a humanitarian crisis.

Article Title: Prevalence and patterns of diabetic ketoacidosis (DKA) among diabetic patients presenting to hospitals in northern state, Sudan: a cross-sectional study during the 2025 humanitarian crisis.

Article References:

Ahmed, A.A.O., Mounfali, M.A.A., Yassin, T. et al. Prevalence and patterns of diabetic ketoacidosis (DKA) among diabetic patients presenting to hospitals in northern state, Sudan: a cross-sectional study during the 2025 humanitarian crisis.
BMC Endocr Disord (2025). https://doi.org/10.1186/s12902-025-02114-9

Image Credits: AI Generated

DOI:

Keywords: Diabetic ketoacidosis, diabetes management, Sudan, humanitarian crisis, healthcare accessibility.

The significance of this research cannot be understated, as hypoglycemia awareness is a crucial protective mechanism for individuals with diabetes. Those who lack awareness are at heightened risk of experiencing severe hypoglycemic events, which can result in detrimental physical and cognitive effects. The study utilized targeted proteomics analysis to identify biomarkers that could shed light on this phenomenon, seeking a clearer understanding of how physiological signals can become disrupted in type 1 diabetes.

AgRP has been long known for its role in appetite regulation and energy balance, but its specific involvement in diabetes-related hypoglycemia awareness raises vital questions about the interplay between energy metabolism and glucose homeostasis. The researchers conducted a comprehensive examination of circulating AgRP levels in individuals diagnosed with type 1 diabetes, carefully comparing those with normal hypoglycemia awareness to those who reported impaired awareness. This comparison revealed a significant decrease in AgRP levels in patients with impaired hypoglycemia awareness, suggesting a potential link between this peptide and the neurocognitive mechanisms at play.

This research opens a new chapter in understanding how hormonal signals can alter awareness and physiological responses to falling glucose levels. The eroding ability to recognize low blood sugar can stem from a range of factors, and AgRP may be one critical piece of the puzzle. By pinpointing lower AgRP levels in individuals with impaired awareness, the study raises the possibility that targeting this pathway could provide novel therapeutic strategies to restore awareness in patients.

Future research could pivot towards exploring whether increasing AgRP could offer a protective effect against hypoglycemia, potentially leading to interventions that may benefit those with type 1 diabetes. Moreover, the therapeutic implications of AgRP extend beyond mere awareness restoration; they could influence hunger regulation, energy expenditure, and overall diabetes management. Thus, the potential impacts of these findings stretch across multiple dimensions of health, requiring a multidisciplinary approach to fully grasp their significance.

Another noteworthy aspect of the study is its innovative methodology, employing state-of-the-art targeted proteomics techniques. Through this approach, researchers could accurately quantify and characterize the plasma levels of AgRP among participants, contributing significantly to the body of knowledge surrounding diabetes pathology. Targeted proteomics enables a deeper understanding of the protein landscape in disease conditions, further underscoring the potential for proteomic signatures to serve as biomarkers for clinical outcomes.

As we navigate this rich tapestry of research, it becomes imperative to consider how these findings resonate with existing knowledge in the field of diabetes. Prior studies have suggested that neuropeptides play a significant role in glucose regulation through various mechanisms, including modulation of food intake and influence on pancreatic function. The current study aligns with and extends this understanding by spotlighting AgRP as a novel player in the hypoglycemia awareness debate, reinforcing the need for relevant neuropeptides to be scrutinized in the context of metabolic health.

For individuals living with type 1 diabetes, the practical implications of lower AgRP levels could be acute. With enhanced understanding of the biochemical pathways involved in hypoglycemia awareness, future strategies may drive the development of therapeutic molecules or guidelines aimed specifically at modulating AgRP levels. Such targeted interventions could equip patients with better tools to navigate their daily lives, mitigating the risk of severe glycemic events and advancing overall diabetes care.

The collaboration among researchers in this study emphasizes the importance of interdisciplinary dialogue. Insights from endocrinology, neurobiology, and metabolic engineering coalesce in a manner that can inform both clinical practice and research pursuits. Engaging with diverse expertise enables a more holistic approach to addressing the multifaceted challenges faced by individuals managing chronic conditions like type 1 diabetes.

In closing, the reported associations between AgRP levels and hypoglycemia awareness present compelling evidence that calls for an urgent reevaluation of existing paradigms in diabetes care. As further investigations expand upon these initial findings, there is immense potential for significant breakthroughs that may not only alter the landscape of diabetes management but also improve the quality of life for countless patients. Awareness, treatment, and ultimately the safeguarding of health outcomes hinge upon such discoveries, making this research a vital step toward a better understanding of type 1 diabetes in the context of neuropeptide signaling.

By embracing the complex mechanisms at play in type 1 diabetes, researchers and healthcare providers can work together to create an informed and responsive framework. Understanding signals like agouti-related protein not only fosters hope for new treatments but also embodies the essence of scientific inquiry—unearthing the unseen connections that define health and disease. As research continues to evolve, collaboration remains key to addressing the ongoing challenges faced by the diabetes community and unveiling the potential for innovation in treatment paradigms.

Subject of Research: The role of agouti-related protein in hypoglycemia awareness among individuals with type 1 diabetes.

Article Title: Targeted proteomics analysis in type 1 diabetes identifies lower agouti-related protein levels in individuals with impaired hypoglycaemia awareness.

Article References:

Varkevisser, R.D.M., Petrera, A., Hauck, S.M. et al. Targeted proteomics analysis in type 1 diabetes identifies lower agouti-related protein levels in individuals with impaired hypoglycaemia awareness.
Sci Rep 15, 36448 (2025). https://doi.org/10.1038/s41598-025-20491-y

Image Credits: AI Generated

DOI: 10.1038/s41598-025-20491-y

Keywords: Type 1 diabetes, hypoglycemia awareness, agouti-related protein, targeted proteomics, biomarkers, neuropeptides, glucose metabolism, metabolic health.

The authors utilized a comprehensive dataset comprised of a substantial cohort of Finnish individuals diagnosed with Type 2 Diabetes. By analyzing longitudinal BMI data alongside glycemic control metrics, the research aimed to uncover trends that can aid in anticipating challenges in diabetes management. As obesity is closely linked to insulin resistance and poor glycemic control, the researchers were particularly keen on dissecting whether rising BMI levels correlate with worsening diabetes management outcomes.

Through rigorous statistical analysis, the study identified notable trends over recent years. The findings revealed not just an increase in the average BMI among participants but also a concerning trend toward deteriorating glycemic control. This sets off alarms about the broader implications for public health. With the simultaneous rise of Type 2 Diabetes and obesity, the results call for urgent action from healthcare systems to tackle this dual epidemic more effectively.

The research also delved into various factors that could contribute to the observed trends. These included lifestyle changes, dietary habits, and socio-economic factors affecting patients. As the study points out, merely tracking BMI is not sufficient; understanding the underlying social determinants of health can lead to more successful interventions. The researchers underscore the importance of adopting a holistic approach to diabetes care that goes beyond medication to include lifestyle modifications and counseling.

Additionally, the role of healthcare providers was discussed extensively in the paper. They are in a unique position to monitor patients not just for baseline metabolic indicators like fasting glucose and HbA1c but also for BMI and potential weight gain trends. This multidimensional approach can better inform the management strategies employed, thereby improving patient outcomes significantly.

The study also highlights the pressing need for increased awareness and education regarding the relationship between weight and diabetes management among patients. Many individuals living with Type 2 Diabetes may not fully understand how excess weight impacts their condition or may underestimate its importance in their daily management efforts. Improving patient knowledge could potentially empower them to make informed lifestyle choices that positively influence their health trajectory.

Furthermore, the findings prompt a necessary conversation about the accessibility of obesity management resources for diabetes patients. Finland’s health system, like many others worldwide, faces gaps in delivering integrated care. Addressing these disparities is vital, as effective obesity interventions can facilitate improved glycemic control and overall health outcomes for diabetic patients.

In a world where the double burden of obesity and diabetes is prevalent, collaboration among various sectors is essential. Governments, healthcare institutions, industry stakeholders, and community organizations must work collectively to develop viable solutions. This multifaceted approach presents opportunities for behavioral interventions, enhanced screening programs, and public health campaigns focused on preventive care.

As the study continues to resonate in the medical community, one can’t help but consider the broader implications. Unchecked obesity and poor glycemic control not only affect individual patient health but can also lead to increased healthcare costs and a burdened healthcare system. Addressing these interconnected issues is crucial for the sustainability of healthcare services and the wellbeing of society as a whole.

The research by Wang et al. exemplifies the critical role that emerging studies can play in shaping public health policy. By providing evidence-based insights, the study advocates for rethinking current diabetes management frameworks and investing in comprehensive educational initiatives that highlight the intricate relationship between weight and glycemic control.

In conclusion, the alarming trajectories observed in Body Mass Index and glycemic control amongst Finnish Type 2 Diabetes patients serve as a clarion call for immediate action. The community of healthcare providers, patients, and policymakers must unite to reverse these trends through effective interventions, education, and increased awareness. If left unaddressed, these trends may culminate in even more severe public health ramifications, further complicating the challenges posed by diabetes management globally.

The importance of such research cannot be overstated. It is vital for ongoing discussions surrounding diabetes treatment and management strategies, providing a pathway toward a healthier future for those affected by this chronic condition. The proactive measures derived from these findings will undoubtedly play a critical role in the evolution of diabetes care, ultimately contributing to improved quality of life for patients struggling to maintain their health.

Subject of Research: The impact of Body Mass Index (BMI) on glycemic control among Finnish patients with Type 2 Diabetes.

Article Title: Time Trends of Body Mass Index and its Impact on Glycemic Control Among Finnish Patients with Type 2 Diabetes.

Article References: Wang, Z., Lavikainen, P., Wikström, K. et al. Time Trends of Body Mass Index and its Impact on Glycemic Control Among Finnish Patients with Type 2 Diabetes. Diabetes Ther 16, 1665–1679 (2025). https://doi.org/10.1007/s13300-025-01763-2

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s13300-025-01763-2

Keywords: Body Mass Index, Glycemic Control, Type 2 Diabetes, Obesity, Public Health, Diabetes Management.

The complexity of healthcare interactions can sometimes amplify feelings of anxiety, particularly among racial and ethnic minorities, as well as younger adults. This demographic often experiences substantial stress when navigating a system that may not be sensitive to their specific needs. The added layer of potential discrimination can further exacerbate these feelings, leading to avoidance behaviors where patients delay or forgo healthcare altogether.

In examining these dynamics, the study identified that higher perceived discrimination was positively correlated with delays in healthcare. This correlation underscores the importance of fostering inclusive and open channels of communication between patients and healthcare professionals. By addressing the root causes of perceived discrimination, hospitals and clinics can help reduce patient anxiety and encourage timely medical interventions.

The investigation revealed a more significant mediation pattern in young adults and racial and ethnic minorities, emphasizing the critical need for tailored strategies that empower these groups. Young adults, who often face unique healthcare challenges, are particularly susceptible to the effects of perceived discrimination. Healthcare providers must remain vigilant in how they engage with patients from diverse backgrounds, acknowledging their experiences while promoting equity in care delivery.

Moreover, it’s essential to recognize that the healthcare experience is not just clinical; it is inherently social. Patients bring their life experiences, cultural context, and feelings towards authority figures into the examination room. Acknowledging and validating these emotions can be pivotal in establishing trust, which is necessary for effective healthcare.

Strategically prioritizing improvement in patient-clinician communication can serve as a mitigating factor against the anxiety associated with perceived discrimination. Training healthcare professionals in cultural competency and emotional intelligence could play an instrumental role in overcoming barriers. Furthermore, employing evidence-based practices that emphasize the importance of empathy and understanding in patient interactions may enhance patient comfort and willingness to seek care.

The implications of this study reach far beyond individual patient interactions; they highlight systemic issues that need addressing at various levels within healthcare systems. Establishing anti-discrimination policies, promoting diversity training for healthcare personnel, and ensuring representation in clinical environments can create more welcoming spaces for all patients.

This research is particularly relevant in current times when the healthcare system is under immense scrutiny. Advocacy for faculty and staff that reflect the demographics of their patient populations could foster a sense of belonging, which is crucial for many individuals accessing healthcare services. As the study suggests, rethinking how healthcare is provided could significantly influence patient outcomes and reduce significant health disparities.

Finally, the conversation around healthcare access should shift towards more inclusive language and payment models that consider the socio-economic factors contributing to perceived discrimination. Policymakers and healthcare leaders must work collaboratively with community organizations to ensure that patients feel safe and valued when seeking care. Such partnerships could bridge gaps that have historically created barriers to accessing adequate healthcare, allowing for a more unified approach to health and wellness.

Addressing perceived discrimination within healthcare settings is not merely an ethical mandate; it is a practical necessity that can lead to improved health outcomes for various marginalized populations. As insights from this research permeate through discussions in the medical community, there lies an opportunity for transformative change rooted in compassion, understanding, and equitable practices.

The ripple effect of engaging with these findings can profoundly enhance the overall healthcare experience, leading to a systemic shift towards greater inclusivity. It is imperative for all stakeholders in the healthcare system to come together and prioritize strategies that not only minimize perceived discrimination but actively advocate for a patient-centric approach grounded in respect and equity.

With these foundational changes, the healthcare landscape can evolve into a space that supports everyone—regardless of race, ethnicity, or age—and provides timely care without the burden of anxiety rooted in discrimination. This fundamental shift would mark a significant step forward in achieving health equity and fostering a system that values all individuals as equal partners in their health journey.

Subject of Research: Perceived Discrimination in Healthcare
Article Title: The Impact of Perceived Discrimination on Healthcare Delay
News Publication Date: October 2023
Web References: https://media.jamanetwork.com/
References: (doi: 10.1001/jamanetworkopen.2025.0046)
Image Credits: JAMA Network Open
Keywords: Racial discrimination, Health care, Ethnicity, Diabetes, Hypertension, Young people, Adults, Patient monitoring, Communications